Current therapy and outcome of Eisenmenger syndrome: data of the German National Register for congenital heart defects

Relation of Digoxin Use in Atrial Fibrillation and the Risk of All-Cause Mortality in Patients ≥65 Years of Age With Versus Without Heart Failure

(2014) Mitesh Shah et al.   AMERICAN JOURNAL OF CARDIOLOGY

Treatment of Group I Pulmonary Arterial Hypertension with Carvedilol Is Safe

(2014) Daniel Grinnan et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Specialized Adult Congenital Heart Disease Care

(2014) Darren Mylotte et al.   CIRCULATION

Pulmonary hypertension in adults with congenital heart disease and Eisenmenger syndrome: current advanced management strategies

(2014) Michele D'Alto et al.   HEART

Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience

(2014) Gerhard-Paul Diller et al.   HEART

Pulmonary arterial hypertension associated with congenital heart disease: Recent advances and future directions

(2014) Michael A. Gatzoulis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Anticoagulation and Survival in Pulmonary Arterial Hypertension

(2013) Karen M. Olsson et al.   CIRCULATION

Effectiveness and Safety of Digoxin Among Contemporary Adults With Incident Systolic Heart Failure

(2013) James V. Freeman et al.  

Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups

(2013) A. Manes et al.   EUROPEAN HEART JOURNAL

Pulmonary hypertension related to congenital heart disease: a call for action

(2013) K. Dimopoulos et al.   EUROPEAN HEART JOURNAL

Impact of Sildenafil on Survival of Patients With Eisenmenger Syndrome

(2013) Yun-Juan Sun et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension

(2013) Jennifer I. Drake et al.   PHYSIOLOGICAL GENOMICS

The Exceptional and Far-Flung Manifestations of Heart Failure in Eisenmenger Syndrome

(2013) Alexander R. Opotowsky et al.   Heart Failure Clinics

Increased mortality among patients taking digoxin--analysis from the AFFIRM study

(2012) M. G. Whitbeck et al.   EUROPEAN HEART JOURNAL

Disease targeting therapies in patients with Eisenmenger syndrome: Response to treatment and long-term efficiency

(2012) Gerhard-Paul Diller et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Adrenergic Receptor Blockade Reverses Right Heart Remodeling and Dysfunction in Pulmonary Hypertensive Rats

(2010) Harm J. Bogaard et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)

(2010) et al.   EUROPEAN HEART JOURNAL

Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology

(2010) Michele D'Alto et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial Hypertension

(2009) Konstantinos Dimopoulos et al.   CIRCULATION

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension study

(2007) Michael A. Gatzoulis et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY